Astellas Oncology Announces Grand Prize Winner in Annual C3 Prize to Cultivate Innovation in Cancer Care Beyond Medicine
Summary
Aimee DeGolyer, Founder & CEO of REPROSENT, based in Los Gatos, California, was chosen as the 2022 Grand Prize winner and will receive a $100,000 grant plus additional resources and hands-on support. The app aims to reduce clinical team burden, drive deeper understanding of the patients daily data and improve outcomes. "This years winner stood out for the creative, patient-centric digital app to help improve the cancer patient journey through better and more accurate communication with their care team. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+\xae healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. The MATTER collaborative includes more than 700 current and alumni startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare.